Understanding the rationale for parenteral ascorbate (Vitamin C) during an acute inflammatory reaction: A biochemical perspective

Critical Care and Resuscitation

Volumn 20, Issue 3, 2018, Pages 174-179

  McNamara, Robert ^a   Deane, Adam M ^b   Anstey, James ^b   Bellomo, Rinaldo ^b,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID;

BLOOD; DOSE RESPONSE; HUMAN; INFLAMMATION; INTENSIVE CARE; PARENTERAL DRUG ADMINISTRATION;

ANTIOXIDANTS; ASCORBIC ACID; CRITICAL CARE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLAMMATION; INFUSIONS, PARENTERAL;

EID: 85054398413     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (93)

1. Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, vitamin C and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest 2017; 151: 1229-38.
2. Fowler AA, Syed AA, Knowlson S, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med 2014; 12: 32.
3. Zabet MH, Mohammadi M, Ramezani M, Khalili H. Effect of high-dose ascorbic acid on vasopressor’s requirement in septic shock. J Res Pharm Pract 2016; 5: 94-100.
4. Wilson JX. Mechanism of action of vitamin C in sepsis: ascorbate modulates redox signaling in endothelium. Biofactors 2009; 35: 5-13.
5. Warren JJ, Mayer JM. Tuning of the thermochemical and kinetic properties of ascorbate by its local environment: solution chemistry and biochemical implications. J Am Chem Soc 2010; 132: 7784-93.
6. Sapper H, Kang SO, Paul HH, Lohmann W. The reversibility of the vitamin C redox system: electrochemical reasons and biological aspects. Z Naturforsch C 1982; 37: 942-6.
7. Harrison FE, May JM. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med 2009; 46: 719-30.
8. May JM, Qu ZC, Meredith ME. Mechanisms of ascorbic acid stimulation of norepinephrine synthesis in neuronal cells. Biochem Biophys Res Commun 2012; 426: 148-52.
9. Carr AC, Shaw GM, Fowler AA, Natarajan R. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock? Crit Care 2015; 19: 418.
10. Murad S, Grove D, Lindberg KA, et al. Regulation of collagen synthesis by ascorbic acid. Proc Natl Acad Sci U S A 1981; 78: 2879-82.
11. Peterkofsky B. Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy. Am J Clin Nutr 1991; 54: 1135S-40S.
12. Kim KH, Seong BL. Peptide amidation: production of peptide hormones in vivo and in vitro. Biotechnol Bioprocess Eng 2001; 6: 244-51.
13. Kolhekar AS, Mains RE, Eipper BA. Peptidylglycine alpha-amidating monooxygenase: an ascorbate-requiring enzyme. Methods Enzymol 1997; 279: 35-43.
14. Eipper BA, Mains RE. The role of ascorbate in the biosynthesis of neuroendocrine peptides. Am J Clin Nutr 1991; 54: 1153S-6S.
15. Dillon PF, Root-Bernstein R, Robinson NE, et al. Receptor-mediated enhancement of beta adrenergic drug activity by ascorbate in vitro and in vivo. PLoS One 2010; 5: e15130.
16. Okamoto K, Tanaka H, Makino Y, Makino I. Restoration of the glucocorticoid receptor function by the phosphodiester compound of vitamins C and E, EPC-K1 (L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl hydrogen phosphate] potassium salt), via a redox-dependent mechanism. Biochem Pharmacol 1998; 56: 79-86.
17. Sawiris PG, Enwonwu CO. Ascorbate deficiency impairs the muscarinic-cholinergic and ss-adrenergic receptor signaling systems in the guinea pig submandibular salivary gland. J Nutr 2000; 130: 2876-82.
18. Dillon PF, Root-Bernstein RS, Lieder CM. Ascorbate enhancement of H1 histamine receptor sensitivity coincides with ascorbate oxidation inhibition by histamine receptors. Am J Physiol Cell Physiol 2006; 291: C977-84.
19. Calero CI, Vickers E, Moraga Cid G, et al. Allosteric modulation of retinal GABA receptors by ascorbic acid. J Neurosci 2011; 31: 9672-82.
20. Camarena V, Wang G. The epigenetic role of vitamin C in health and disease. Cell Mol Life Sci 2016; 73: 1645-58.
21. Kagan VE, Serbinova EA, Forte T, et al. Recycling of vitamin E in human low density lipoproteins. J Lipid Res 1992; 33: 385-97.
22. Constantinescu A, Han D, Packer L. Vitamin E recycling in human erythrocyte membranes. J Biol Chem 1993; 268: 10906-13.
23. Padh H. Vitamin C: newer insights into its biochemical functions. Nutr Rev 1991; 49: 65-70.
24. May JM, Qu ZC, Mendiratta S. Protection and recycling of alpha-tocopherol in human erythrocytes by intracellular ascorbic acid. Arch Biochem Biophys 1998; 349: 281-9.
25. Figueroa-Méndez R, Rivas-Arancibia S. Vitamin C in health and disease: its role in the metabolism of cells and redox state in the brain. Front Physiol 2015; 6: 397.
26. Mandl J, Szarka A, Banhegyi G. Vitamin C: update on physiology and pharmacology. Br J Pharmacol 2009; 157: 1097-110.
27. Heller R, Unbehaun A, Schellenberg B, et al. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 2001; 276: 40-7.
28. Kietadisorn R, Juni RP, Moens AL. Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities. Am J Physiol Endocrinol Metab 2012; 302: E481-95.
29. Salnikow K, Kasprzak KS. Ascorbate depletion: a critical step in nickel carcinogenesis? Environ Health Perspect 2005; 113: 577-84.
30. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 2004; 36: 1-12.
31. Chatterjee M, Saluja R, Kumar V, et al. Ascorbate sustains neutrophil NOS expression, catalysis, and oxidative burst. Free Radic Biol Med 2008; 45: 1084-93.
32. May JM, Harrison FE. Role of vitamin C in the function of the vascular endothelium. Antioxid Redox Signal 2013; 19: 2068-83.
33. Tyml K. Vitamin C and microvascular dysfunction in systemic inflammation. Antioxidants (Basel) 2017; 6: E49.
34. Creery D, Fraser DD. Tissue dysoxia in sepsis: getting to know the mitochondrion. Crit Care Med 2002; 30: 483-4.
35. Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006; 70: 1469-80.
36. Hirota K. Involvement of hypoxia-inducible factors in the dysregulation of oxygen homeostasis in sepsis. Cardiovasc Hematol Disord Drug Targets 2015; 15: 29-40.
37. Bozonet SM, Carr AC, Pullar JM, Vissers MC. Enhanced human neutrophil vitamin C status, chemotaxis and oxidant generation following dietary supplementation with vitamin C-rich SunGold kiwifruit. Nutrients 2015; 7: 2574-88.
38. Carr AC, Maggini S. Vitamin C and immune function. Nutrients 2017; 9: E1211.
39. Frei B, Stocker R, England L, Ames BN. Ascorbate: the most effective antioxidant in human blood plasma. Adv Exp Med Biol 1990; 264: 155-63.
40. Schorah CJ, Downing C, Piripitsi A, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 1996; 63: 760-5.
41. Long CL, Maull KI, Krishnan RS, et al. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 2003; 109: 144-8.
42. de Grooth HJ, Manubulu-Choo WP, Zandvliet AS, et al. Vitamin C pharmacokinetics in patients who are critically ill: a randomized trial of four IV regimens. Chest 2018; 153: 1368-77.
43. Cristofori L, Tavazzi B, Gambin R, et al. Early onset of lipid peroxidation after human traumatic brain injury: a fatal limitation for the free radical scavenger pharmacological therapy? J Investig Med 2001; 49: 450-8.
44. Camps J, García-Heredia A. Introduction: oxidation and inflammation, a molecular link between non-communicable diseases. Adv Exp Med Biol 2014; 824: 1-4.
45. Bar-Or D, Bar-Or R, Rael LT, Brody EN. Oxidative stress in severe acute illness. Redox Biol 2015; 4: 340-5.
46. May JM, Qu ZC, Cobb CE. Human erythrocyte recycling of ascorbic acid: relative contributions from the ascorbate free radical and dehydroascorbic acid. J Biol Chem 2004; 279: 14975-82.
47. Nemet I, Monnier VM. Vitamin C degradation products and pathways in the human lens. J Biol Chem 2011; 286: 37128-36.
48. Blake DR, Allen RE, Lunec J. Free radicals in biological systems--a review orientated to inflammatory processes. Br Med Bull 1987; 43: 371-85.
49. May JM, Qu ZC, Neel DR, Li X. Recycling of vitamin C from its oxidized forms by human endothelial cells. Biochim Biophys Acta 2003; 1640: 153-61.
50. Rivas CI, Zúñiga FA, Salas-Burgos A, et al. Vitamin C transporters. J Physiol Biochem 2008; 64: 357-75.
51. Savini I, Rossi A, Pierro C, et al. SVCT1 and SVCT2: key proteins for vitamin C uptake. Amino Acids 2008; 34: 347-55.
52. Boyer JC, Campbell CE, Sigurdson WJ, Kuo SM. Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells. Biochem Biophys Res Commun 2005; 334: 150-6.
53. Thorens B, Mueckler M. Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab 2010; 298: E141-5.
54. Deane AM, Rayner CK, Keeshan A, et al. The effects of critical illness on intestinal glucose sensing, transporters, and absorption. Crit Care Med 2014; 42: 57-65.
55. Oreopoulos DG, Lindeman RD, VanderJagt DJ, et al. Renal excretion of ascorbic acid: effect of age and sex. J Am Coll Nutr 1993; 12: 537-42.
56. Blanchard J, Tozer TN, Rowland M. Pharmacokinetic perspectives on megadoses of ascorbic acid. Am J Clin Nutr 1997; 66: 1165-71.
57. Wilson JX. Evaluation of vitamin C for adjuvant sepsis therapy. Antioxid Redox Signal 2013; 19: 2129-40.
58. Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006; 113: 1708-14.
59. Secor D, Swarbreck S, Ellis CG, et al. Ascorbate inhibits platelet-endothelial adhesion in an in-vitro model of sepsis via reduced endothelial surface P-selectin expression. Blood Coagul Fibrinolysis 2017; 28: 28-33.
60. Parker WH, Qu ZC, May JM. Intracellular ascorbate prevents endothelial barrier permeabilization by thrombin. J Biol Chem 2015; 290: 21486-97.
61. Song J, Park J, Kim JH, et al. Dehydroascorbic acid attenuates ischemic brain edema and neurotoxicity in cerebral ischemia: an in vivo study. Exp Neurobiol 2015; 24: 41-54.
62. Corcoran SE, O’Neill LA. HIF1α and metabolic reprogramming in inflammation. J Clin Invest 2016; 126: 3699-707.
63. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 2003; 278: 22546-54.
64. Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002; 236: 814-22.
65. Berger MM, Soguel L, Shenkin A, et al. Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Crit Care 2008; 12: R101.
66. Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013; 368: 1489-97.
67. Ayatollahi V, Dehghanpour Farashah S, Behdad S, et al. Effect of intravenous vitamin C on postoperative pain in uvulopalatopharyngoplasty with tonsillectomy. Clin Otolaryngol 2017; 42: 139-43.
68. Beale RJ, Sherry T, Lei K, et al. Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial. Crit Care Med 2008; 36: 131-44.
69. Traber MG, Stevens JF. Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radic Biol Med 2011; 51: 1000-13.
70. Royal College of Pathologists of Australia. RCPA Manual 7th edition [website]. RCPA,.2015. https://www.rcpa.edu.au/Library/Practising-Pathology/RCPA-Manual/Items/Pathology-Tests/V/Vitamin-C (viewed June 2018).
71. Carr AC, Rosengrave PC, Bayer S, et al. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care 2017; 21: 300.
72. Rümelin A, Jaehde U, Kerz T, et al. Early postoperative substitution procedure of the antioxidant ascorbic acid. J Nutr Biochem 2005; 16: 104-8.
73. Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med 2004; 140: 533-7.
74. Duconge J, Miranda-Massari JR, Gonzalez MJ, et al. Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate. P R Health Sci J 2008; 27: 7-19.
75. Hosein S, Udy AA, Lipman J. Physiological changes in the critically ill patient with sepsis. Curr Pharm Biotechnol 2011; 12: 1991-5.
76. Buehner M, Pamplin J, Studer L, et al. Oxalate nephropathy after continuous infusion of high-dose vitamin C as an adjunct to burn resuscitation. J Burn Care Res 2016; 37: e374-9.
77. Padayatty SJ, Sun AY, Chen Q, et al. Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One 2010; 5: e11414.
78. Hoffer LJ, Levine M, Assouline S, et al. Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol 2008; 19: 1969-74.
79. Stephenson CM, Levin RD, Spector T, Lis CG. Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother Pharmacol 2013; 72: 139-46.
80. Cossey LN, Rahim F, Larsen CP. Oxalate nephropathy and intravenous vitamin C. Am J Kidney Dis 2013; 61: 1032-5.
81. Knight J, Madduma-Liyanage K, Mobley JA, et al. Ascorbic acid intake and oxalate synthesis. Urolithiasis 2016; 44: 289-97.
82. Hatch M, Mulgrew S, Bourke E, et al. Effect of megadoses of ascorbic acid on serum and urinary oxalate. Eur Urol 1980; 6: 166-9.
83. Lyon ME, Baskin LB, Braakman S, et al. Interference studies with two hospital-grade and two home-grade glucose meters. Diabetes Technol Ther 2009; 11: 641-7.
84. Lyon ME, DuBois JA, Fick GH, Lyon AW. Estimates of total analytical error in consumer and hospital glucose meters contributed by hematocrit, maltose, and ascorbate. J Diabetes Sci Technol 2010; 4: 1479-94.
85. Kim SK, Hahm JR, Kim HS, et al. Spurious elevation of glucose concentration during administration of high dose of ascorbic acid in a patient with type 2 diabetes on hemodialysis. Yonsei Med J 2013; 54: 1289-92.
86. Martinello F, Luiz da Silva E. Mechanism of ascorbic acid interference in biochemical tests that use peroxide and peroxidase to generate chromophore. Clin Chim Acta 2006; 373: 108-16.
87. Vasudevan S, Hirsch IB. Interference of intravenous vitamin C with blood glucose testing. Diabetes Care 2014; 37: e93-4.
88. Cho J, Ahn S, Yim J, et al. Influence of vitamin C and maltose on the accuracy of three models of glucose meters. Ann Lab Med 2016; 36: 271-4.
89. 18F-FDG PET imaging. J Nucl Med Technol 2015; 43: 70-1.
90. Honore PM, Jacobs R, Hendrickx I, et al. Adjuvant vitamin C treatment in sepsis-how many oranges a day keep (vasopressor-dependent) septic shock away? J Thorac Dis 2016; 8: E993-5.
91. Siriwardena AK, Mason JM, Balachandra S, et al. Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis. Gut 2007; 56: 1439-44.
92. van Zanten AR, Sztark F, Kaisers UX, et al. High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA 2014; 312: 514-24.
93. Antonic M, Lipovec R, Gregorcic F, et al. Perioperative ascorbic acid supplementation does not reduce the incidence of postoperative atrial fibrillation in on-pump coronary artery bypass graft patients. J Cardiol 2017; 69: 98-102.